CovidChloroV1, Main, Corpus, bibRecord, 001618

Management and Treatment of COVID-19: The Chinese Experience.

Identifieur interne : 001618 ( Main/Corpus ); précédent : 001617; suivant : 001619

Management and Treatment of COVID-19: The Chinese Experience.

Auteurs : Fujun Peng ; Lei Tu ; Yongshi Yang ; Peng Hu ; Runsheng Wang ; Qinyong Hu ; Feng Cao ; Taijiao Jiang ; Jinlyu Sun ; Guogang Xu ; Christopher Chang

Source :

The Canadian journal of cardiology [ 1916-7075 ] ; 2020.

RBID : pubmed:32439306

English descriptors

KwdEn :
- Betacoronavirus (isolation & purification), Betacoronavirus (pathogenicity), COVID-19 (MeSH), China (epidemiology), Communicable Disease Control (methods), Communicable Disease Control (organization & administration), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Coronavirus Infections (transmission), Humans (MeSH), Pandemics (prevention & control), Patient Care Management (methods), Patient Care Management (organization & administration), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Pneumonia, Viral (therapy), Pneumonia, Viral (transmission), SARS-CoV-2 (MeSH).
MESH :
- geographic , epidemiology : China.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- methods : Communicable Disease Control, Patient Care Management.
- organization & administration : Communicable Disease Control, Patient Care Management.
- pathogenicity : Betacoronavirus.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Humans, SARS-CoV-2.

Abstract

With more than 1,800,000 cases and 110,000 deaths globally, COVID-19 is one of worst infectious disease outbreaks in history. This paper provides a critical review of the available evidence regarding the lessons learned from the Chinese experience with COVID-19 prevention and management. The steps that have led to a near disappearance of new cases in China included rapid sequencing of the virus to establish testing kits, which allowed tracking of infected persons in and out of Wuhan. In addition, aggressive quarantine measures included the complete isolation of Wuhan and then later Hubei Province and the rest of the country, as well as closure of all schools and nonessential businesses. Other measures included the rapid construction of two new hospitals and the establishment of "Fangcang" shelter hospitals. In the absence of a vaccine, the management of COVID-19 included antivirals, high-flow oxygen, mechanical ventilation, corticosteroids, hydroxychloroquine, tocilizumab, interferons, intravenous immunoglobulin, and convalescent plasma infusions. These measures appeared to provide only moderate success. Although some measures have been supported by weak descriptive data, their effectiveness is still unclear pending well controlled clinical trials. In the end, it was the enforcement of drastic quarantine measures that stopped SARS-CoV-2 from spreading. The earlier the implementation, the less likely resources will be depleted. The most critical factors in stopping a pandemic are early recognition of infected individuals, carriers, and contacts and early implementation of quarantine measures with an organised, proactive, and unified strategy at a national level. Delays result in significantly higher death tolls.

DOI: 10.1016/j.cjca.2020.04.010
PubMed: 32439306
PubMed Central: PMC7162773

Links to Exploration step

pubmed:32439306

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management and Treatment of COVID-19: The Chinese Experience.</title>
<author><name sortKey="Peng, Fujun" sort="Peng, Fujun" uniqKey="Peng F" first="Fujun" last="Peng">Fujun Peng</name>
<affiliation><nlm:affiliation>Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tu, Lei" sort="Tu, Lei" uniqKey="Tu L" first="Lei" last="Tu">Lei Tu</name>
<affiliation><nlm:affiliation>Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Yongshi" sort="Yang, Yongshi" uniqKey="Yang Y" first="Yongshi" last="Yang">Yongshi Yang</name>
<affiliation><nlm:affiliation>Department of Allergy and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Peng" sort="Hu, Peng" uniqKey="Hu P" first="Peng" last="Hu">Peng Hu</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Runsheng" sort="Wang, Runsheng" uniqKey="Wang R" first="Runsheng" last="Wang">Runsheng Wang</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Qinyong" sort="Hu, Qinyong" uniqKey="Hu Q" first="Qinyong" last="Hu">Qinyong Hu</name>
<affiliation><nlm:affiliation>Renmin Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cao, Feng" sort="Cao, Feng" uniqKey="Cao F" first="Feng" last="Cao">Feng Cao</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jiang, Taijiao" sort="Jiang, Taijiao" uniqKey="Jiang T" first="Taijiao" last="Jiang">Taijiao Jiang</name>
<affiliation><nlm:affiliation>Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China. Electronic address: taijiao@ibms.pumc.edu.cn.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sun, Jinlyu" sort="Sun, Jinlyu" uniqKey="Sun J" first="Jinlyu" last="Sun">Jinlyu Sun</name>
<affiliation><nlm:affiliation>Department of Allergy and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Beijing, China. Electronic address: sunjinlv@pumch.cn.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Xu, Guogang" sort="Xu, Guogang" uniqKey="Xu G" first="Guogang" last="Xu">Guogang Xu</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. Electronic address: guogang_xu@qq.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chang, Christopher" sort="Chang, Christopher" uniqKey="Chang C" first="Christopher" last="Chang">Christopher Chang</name>
<affiliation><nlm:affiliation>Division of Pediatric Immunology and Allergy, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA; Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, California, USA. Electronic address: chrchang@mhs.net.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32439306</idno>
<idno type="pmid">32439306</idno>
<idno type="doi">10.1016/j.cjca.2020.04.010</idno>
<idno type="pmc">PMC7162773</idno>
<idno type="wicri:Area/Main/Corpus">001618</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001618</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Management and Treatment of COVID-19: The Chinese Experience.</title>
<author><name sortKey="Peng, Fujun" sort="Peng, Fujun" uniqKey="Peng F" first="Fujun" last="Peng">Fujun Peng</name>
<affiliation><nlm:affiliation>Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tu, Lei" sort="Tu, Lei" uniqKey="Tu L" first="Lei" last="Tu">Lei Tu</name>
<affiliation><nlm:affiliation>Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Yongshi" sort="Yang, Yongshi" uniqKey="Yang Y" first="Yongshi" last="Yang">Yongshi Yang</name>
<affiliation><nlm:affiliation>Department of Allergy and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Peng" sort="Hu, Peng" uniqKey="Hu P" first="Peng" last="Hu">Peng Hu</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Runsheng" sort="Wang, Runsheng" uniqKey="Wang R" first="Runsheng" last="Wang">Runsheng Wang</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Qinyong" sort="Hu, Qinyong" uniqKey="Hu Q" first="Qinyong" last="Hu">Qinyong Hu</name>
<affiliation><nlm:affiliation>Renmin Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cao, Feng" sort="Cao, Feng" uniqKey="Cao F" first="Feng" last="Cao">Feng Cao</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jiang, Taijiao" sort="Jiang, Taijiao" uniqKey="Jiang T" first="Taijiao" last="Jiang">Taijiao Jiang</name>
<affiliation><nlm:affiliation>Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China. Electronic address: taijiao@ibms.pumc.edu.cn.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sun, Jinlyu" sort="Sun, Jinlyu" uniqKey="Sun J" first="Jinlyu" last="Sun">Jinlyu Sun</name>
<affiliation><nlm:affiliation>Department of Allergy and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Beijing, China. Electronic address: sunjinlv@pumch.cn.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Xu, Guogang" sort="Xu, Guogang" uniqKey="Xu G" first="Guogang" last="Xu">Guogang Xu</name>
<affiliation><nlm:affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. Electronic address: guogang_xu@qq.com.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chang, Christopher" sort="Chang, Christopher" uniqKey="Chang C" first="Christopher" last="Chang">Christopher Chang</name>
<affiliation><nlm:affiliation>Division of Pediatric Immunology and Allergy, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA; Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, California, USA. Electronic address: chrchang@mhs.net.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The Canadian journal of cardiology</title>
<idno type="eISSN">1916-7075</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>COVID-19 (MeSH)</term>
<term>China (epidemiology)</term>
<term>Communicable Disease Control (methods)</term>
<term>Communicable Disease Control (organization & administration)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Patient Care Management (methods)</term>
<term>Patient Care Management (organization & administration)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>China</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term>
<term>Patient Care Management</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term>
<term>Patient Care Management</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">With more than 1,800,000 cases and 110,000 deaths globally, COVID-19 is one of worst infectious disease outbreaks in history. This paper provides a critical review of the available evidence regarding the lessons learned from the Chinese experience with COVID-19 prevention and management. The steps that have led to a near disappearance of new cases in China included rapid sequencing of the virus to establish testing kits, which allowed tracking of infected persons in and out of Wuhan. In addition, aggressive quarantine measures included the complete isolation of Wuhan and then later Hubei Province and the rest of the country, as well as closure of all schools and nonessential businesses. Other measures included the rapid construction of two new hospitals and the establishment of "Fangcang" shelter hospitals. In the absence of a vaccine, the management of COVID-19 included antivirals, high-flow oxygen, mechanical ventilation, corticosteroids, hydroxychloroquine, tocilizumab, interferons, intravenous immunoglobulin, and convalescent plasma infusions. These measures appeared to provide only moderate success. Although some measures have been supported by weak descriptive data, their effectiveness is still unclear pending well controlled clinical trials. In the end, it was the enforcement of drastic quarantine measures that stopped SARS-CoV-2 from spreading. The earlier the implementation, the less likely resources will be depleted. The most critical factors in stopping a pandemic are early recognition of infected individuals, carriers, and contacts and early implementation of quarantine measures with an organised, proactive, and unified strategy at a national level. Delays result in significantly higher death tolls.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32439306</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7075</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>36</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
</PubDate>
</JournalIssue>
<Title>The Canadian journal of cardiology</Title>
<ISOAbbreviation>Can J Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Management and Treatment of COVID-19: The Chinese Experience.</ArticleTitle>
<Pagination><MedlinePgn>915-930</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0828-282X(20)30395-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjca.2020.04.010</ELocationID>
<Abstract><AbstractText>With more than 1,800,000 cases and 110,000 deaths globally, COVID-19 is one of worst infectious disease outbreaks in history. This paper provides a critical review of the available evidence regarding the lessons learned from the Chinese experience with COVID-19 prevention and management. The steps that have led to a near disappearance of new cases in China included rapid sequencing of the virus to establish testing kits, which allowed tracking of infected persons in and out of Wuhan. In addition, aggressive quarantine measures included the complete isolation of Wuhan and then later Hubei Province and the rest of the country, as well as closure of all schools and nonessential businesses. Other measures included the rapid construction of two new hospitals and the establishment of "Fangcang" shelter hospitals. In the absence of a vaccine, the management of COVID-19 included antivirals, high-flow oxygen, mechanical ventilation, corticosteroids, hydroxychloroquine, tocilizumab, interferons, intravenous immunoglobulin, and convalescent plasma infusions. These measures appeared to provide only moderate success. Although some measures have been supported by weak descriptive data, their effectiveness is still unclear pending well controlled clinical trials. In the end, it was the enforcement of drastic quarantine measures that stopped SARS-CoV-2 from spreading. The earlier the implementation, the less likely resources will be depleted. The most critical factors in stopping a pandemic are early recognition of infected individuals, carriers, and contacts and early implementation of quarantine measures with an organised, proactive, and unified strategy at a national level. Delays result in significantly higher death tolls.</AbstractText>
<CopyrightInformation>Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName>
<ForeName>Fujun</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tu</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Yongshi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Runsheng</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Qinyong</ForeName>
<Initials>Q</Initials>
<AffiliationInfo><Affiliation>Renmin Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cao</LastName>
<ForeName>Feng</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jiang</LastName>
<ForeName>Taijiao</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China. Electronic address: taijiao@ibms.pumc.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sun</LastName>
<ForeName>Jinlyu</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, Beijing, China. Electronic address: sunjinlv@pumch.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Xu</LastName>
<ForeName>Guogang</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory Medicine, Second Medical Center and National Clinical Research Center for Geriatric Diseases, Medical College of the People's Liberation Army, Chinese People's Liberation Army General Hospital, Beijing, China. Electronic address: guogang_xu@qq.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chang</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Division of Pediatric Immunology and Allergy, Joe DiMaggio Children's Hospital, Hollywood, Florida, USA; Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, California, USA. Electronic address: chrchang@mhs.net.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Can J Cardiol</MedlineTA>
<NlmUniqueID>8510280</NlmUniqueID>
<ISSNLinking>0828-282X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003140" MajorTopicYN="Y">Communicable Disease Control</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010346" MajorTopicYN="Y">Patient Care Management</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32439306</ArticleId>
<ArticleId IdType="pii">S0828-282X(20)30395-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.cjca.2020.04.010</ArticleId>
<ArticleId IdType="pmc">PMC7162773</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Virol Sin. 2020 Jun;35(3):266-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32125642</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Heart J. 2020 May 14;41(19):1791-1794</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32232396</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Apr 18;395(10232):1305-1314</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32247320</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EClinicalMedicine. 2020 Apr 05;21:100331</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32292899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Nov 19;71(16):2089-2098</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32361738</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2020 May 14;16(5):e1008421</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32407364</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32043983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergy. 2020 Jul;75(7):1730-1741</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thorac Oncol. 2020 May;15(5):700-704</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32114094</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Apr 7;323(13):1239-1242</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2013 Apr;57(4):1743-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23357765</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nurs Res Pract. 2011;2011:260482</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21994818</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32164085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Nurs Sci. 2020 Apr 04;7(2):128-134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32292634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32196083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Am Thorac Soc. 2017 Oct;14(Supplement_4):S261-S270</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28985479</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2013 Jun 6;368(23):2159-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23688302</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 May 8;368(6491):638-642</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32234804</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):727-732</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32196410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jun;92(6):602-611</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32104911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32085846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Intensive Care Med. 2020 Feb;46(2):315-328</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32040667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Discov Ther. 2020;14(1):58-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32147628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 29;395(10225):683-684</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32122468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 8;395(10222):391-393</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32035533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2019 Sep 4;23(1):300</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31484582</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Feb 19;368:m606</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):69-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31996494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25030060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Intensive Care Med. 2012 Mar;38(3):458-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22318634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 7;395(10226):809-815</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32151335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2012 Jun 20;307(23):2526-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jun;92(6):612-617</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32108351</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 24;48(3):189-194</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32234175</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32064853</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Signal Transduct Target Ther. 2020 Feb 21;5(1):18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32296012</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Aug 28;10(8):e0136520</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26317621</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):183-184</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32164084</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Host Microbe. 2020 Mar 11;27(3):325-328</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32035028</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1253-1258</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32281333</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 7;395(10226):755</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32145772</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2020 May 14;181(4):905-913.e7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32333836</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Heart J. 2020 May 14;41(19):1788-1790</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32242895</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):970-971</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32003551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chin Med J (Engl). 2020 May 5;133(9):1080-1086</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32149773</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001618 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001618 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32439306
   |texte=   Management and Treatment of COVID-19: The Chinese Experience.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32439306" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Management and Treatment of COVID-19: The Chinese Experience.

Management and Treatment of COVID-19: The Chinese Experience.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki